Acuity and colour vision changes post intravitreal dexamethasone implant injection in patients with diabetic macular oedema.
PURPOSE:To evaluate changes in colour vision following intravitreal injection of Dexamethasone implant (Ozurdex) in patients with diabetic macular oedema (DMO). Both red-green (RG) and yellow-blue (YB) chromatic sensitivity were assessed using the Colour Assessment & Diagnosis (CAD) test which i...
Main Authors: | Ahmed Abdel-Hay, Sobha Sivaprasad, Ahalya Subramanian, John L Barbur |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6019681?pdf=render |
Similar Items
-
Budget impact analysis of dexamethasone intravitreal implant for the treatment of diabetic macular oedema
by: Fernando de Andrés-Nogales, et al.
Published: (2018-11-01) -
Macular Oedema Related to Idiopathic Macular Telangiectasia Type 1 Treated with Dexamethasone Intravitreal Implant (Ozurdex)
by: Mohamed Loutfi, et al.
Published: (2014-01-01) -
Indicators of Visual Prognosis in Diabetic Macular Oedema
by: Sagnik Sen, et al.
Published: (2021-05-01) -
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
by: S. K. Mishra, et al.
Published: (2018-03-01) -
Intravitreal dexamethasone implants for diabetic macular edema
by: Alicia Pareja-Ríos, et al.
Published: (2018-01-01)